about
Liver pathology of hepatitis C, beyond grading and staging of the diseaseLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver diseaseProlonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonRole of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular DamageEpidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis.Proteomic analysis for developing new biomarkers of hepatocellular carcinoma.Long-term effects of antiviral therapy in patients with chronic hepatitis C.Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study.HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients.YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis CThe interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C.Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.Hyperferritinemia is a risk factor for steatosis in chronic liver disease.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Hepatitis C virus infection and mixed cryoglobulinemiaLiver Fibrosis Quantification by Magnetic Resonance Imaging.Investigation of the direct hepatic effects of intramuscular interleukin-8 injection in an experimental rabbit model.High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines.Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.Deep learning enables automated scoring of liver fibrosis stages
P2860
Q26773294-2E41A673-6CCE-46E7-B999-296DD7901799Q26777511-4B5D5911-31CA-4347-AA89-9D8EE6261E13Q27481042-5EA5482A-ADE1-471E-AD7C-FF9CA85B2CB0Q27487518-32454E23-ED79-4FD6-BC33-B95A3741A511Q27490515-18128070-872D-43D4-91AA-B08BCCD112C4Q33863710-D270AC61-2DAE-435C-9C56-76EC2EF15642Q33866383-AB49874A-C37A-4DE5-BD04-9B70576677E5Q34124107-4EEDC37E-4504-43DD-81C0-90A3B9D2285CQ34310597-F3747548-01D0-4805-B3E9-9D8A8E685C6CQ34390244-42BF547C-0983-4BD7-B907-0FFC041B635DQ34415157-7E10EA67-81F3-4F0B-AB0C-3D5719B553FEQ34778315-739364B6-5CC5-4A4A-AC4E-6FEA7C502698Q34825783-4671D86A-ED0E-497F-B771-DA739FEB592EQ35188071-79715391-91AD-48E6-B289-90EF6EAF890FQ35823055-5B3878EE-DAB2-418C-A161-69405FAC37BEQ36042542-3136DFF5-9FDB-476F-83DC-B7E378B68ECFQ36104827-F004DB19-C694-428E-85DF-885765596CC6Q36972406-3BB76A33-2055-4CED-8BB8-B6CC693388DBQ37086216-375F51F8-51B5-4AD5-9CCA-896A6FC27FDBQ37182959-4C053A2C-418B-4622-A248-EEDB6A83B01CQ37192623-2D91BEBD-EDE2-40F5-9458-FA9DBDEB60E7Q38030533-9F7378E1-576A-4B60-A220-BA5AE916F980Q38600259-CFECAD4A-8D69-4E15-ABE2-EBCEDB31F90AQ42934569-60FBE0E1-05A0-4534-BD96-B88E147DDD8AQ49305575-EF79D5E7-7EEF-4EDB-AD84-F1731570B426Q52692830-E4CE75EB-8D29-4337-8CAE-7B55C472F575Q58099005-70128D80-CBD0-40E5-A75F-4946F18E0D74
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Chronic hepatitis: morphology and nomenclature.
@en
type
label
Chronic hepatitis: morphology and nomenclature.
@en
prefLabel
Chronic hepatitis: morphology and nomenclature.
@en
P1433
P1476
Chronic hepatitis: morphology and nomenclature
@en
P2093
P304
P577
1994-08-01T00:00:00Z